<DOC>
	<DOCNO>NCT01095133</DOCNO>
	<brief_summary>The purpose research study learn whether treat esophagus amiloride reduces either frequency time onset acid-induced heartburn patient nonerosive reflux disease . In particular , look people either complete relief use Proton Pump Inhibitor ( PPI ) relief symptom PPI .</brief_summary>
	<brief_title>Do Acid Sensing Ion Channels Contribute Heartburn ?</brief_title>
	<detailed_description>It well establish patient gastroesophageal reflux disease - erosive non-erosive form - esophageal biopsy lesion esophageal stratify squamous epithelium know 'dilated intercellular space ( DIS ) . This lesion importance reflect increase paracellular permeability due acid damage tight junction [ 1 ] . Moreover , increase paracellular permeability non-eroded esophageal epithelium provide plausible explanation heartburn occur episode acid reflux ( esophageal acid perfusion ) nonerosive reflux disease ( NERD ) healthy subject , luminal acid able diffuse cell quantity sufficient acidify intercellular space [ 2 ] . Further , lower intercellular pH likely trigger heartburn ability stimulate pain-sensing neuron ( nociceptors ) within esophageal mucosa ; signal neuron transmit CNS heartburn perception . Clinical experimental evidence support concept antacid ingestion relief proton pump inhibitor ( PPIs ) prevent heartburn patient PPIs control heartburn , also lead resolution DIS squamous epithelium [ 3 ] . Moreover , increasingly likely many NERD patient classify PPI-partial responder develop heartburn mechanism PPI-complete responder NERD . This PPIs raise gastric pH ~pH 5 , even 'weakly-acidic ' refluxates show associated heartburn [ 4 ] . The reason presence break epithelial barrier , weakly acidic refluxates still able acidify intercellular space level sufficient activate nociceptors - latter case since nociceptors activate even pHs modestly acidic pH 6.0-pH 7.0 ( see ) . The esophageal mucosa two nociceptors candidate mediate heartburn NERD . These : ) capsaicin-sensitive , transient receptor potential vanilloid receptor ( TRPV ) -1 , b ) amiloride-inhibitable , acid-sensing ion channel ( ASIC ) , subtype 2 . Both nociceptor type innervate esophageal mucosa activate small decline environmental ( intercellular ) pH [ 5,6 ] . Recently , role TRPV-1 seek causation heartburn esophageal acid perfusion [ 7 ] . This do perfusing esophagus capsaicin quantity presume sufficient desensitize TRPV-1 perfusing acid see block heartburn . The result , however , negative acid still elicit heartburn . From , one conclude heartburn either mediate TRPV-1 capsaicin fail adequately desensitize TRPV-1 . We propose test hypothesis capsaicin 's failure block heartburn subject actual nociceptors mediate heartburn mucosal ASICs rather TRPV-1 . The hypothesis test double-blind crossover study design determine esophagal perfusion ASIC-inhibitor , amiloride , block heartburn elicit acid-perfusion PPI-complete responder PPI-partial responder NERD [ 8 ] . The expectation , compare placebo , amiloride , readily diffuse across intact esophageal epithelium , reduce frequency prolong onset reduce severity heartburn elicitable esophageal acid perfusion . Such outcome would provide support mucosal ASICs , rather TRPV-1 , mediator heartburn NERD , raise interest ASICs potential therapeutic target subset NERD PPI-partial responder .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Amiloride</mesh_term>
	<criteria>Adults , 1859 year old moderate heartburn least 3 days/week male nonpregnant/nonlactating female Complete relief use PPI relief symptom PPI erosive esophagitis unable unwilling undergo endoscopy biopsy Bernstein test eosinophilic esophagitis negative Bernstein test know hypersensitivity amiloride renal disease diabetes hypotension electrolyte imbalance contraindication diuretic , include take lithium ACE inhibitor . history gastric esophageal surgery history ZE syndrome bleed disorder UGI bleed esophageal motor disorder esophageal stricture Barrett 's esophagus UGI malignancy esophageal varix subject current malabsorption inflammatory bowel disease severe heartlungliverrenalcerebrovascular disease subject posttransplant diabetes actively take follow medication : tricyclic antidepressant , quinidine , quinine , dilantin , warfarin , narcotic analgesic , antineoplastic agent , salicylate ( except baby aspirin cardiovascular protection ) ; steroid , NSAIDs ( include COX2 inhibitor ) , KCl , antituberculosis medication , bisphosphonates , triamterene , cyclosporine , tacrolimus , potassium spar drug like spironolactone serum potassium 5.5 mEq/L high</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Gastroesophageal reflux disease</keyword>
	<keyword>Heartburn</keyword>
</DOC>